New Data from Corvus Phase 1 Study of CPI-006 Continues to Support its Potential as a Treatment for COVID-19GlobeNewsWire • 10/05/20
New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020GlobeNewsWire • 09/17/20
Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19GlobeNewsWire • 09/10/20
Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual ConferenceGlobeNewsWire • 08/04/20
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial ResultsGlobeNewsWire • 07/30/20
Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020GlobeNewsWire • 07/23/20
Corvus Gold Announces Brand New Oxide Gold Discovery at the Lynnda Strip Target, 2.5 kilometres North of the Mother Lode Deposit with 44m @ 0.90 g/t Gold and 20m @ 0.74 g/t Gold within 197m @ 0.44 g/t GoldGlobeNewsWire • 07/16/20
Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19GlobeNewsWire • 07/07/20
Corvus Pharmaceuticals Presents Updated Clinical Data Supporting and Refining the Adenosine Gene Signature’s Ability to Identify Patients Likely to Respond to Treatment with CiforadenantGlobeNewsWire • 05/29/20
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/02/20
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/06/20
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial ResultsGlobeNewsWire • 03/05/20
Richard Miller Awarded 2020 Drug Hunter Award by UC Drug Discovery ConsortiumGlobeNewsWire • 02/19/20
Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual MeetingGlobeNewsWire • 12/07/19
Corvus Pharmaceuticals Presents Updated Data from CPI-006 Phase 1/1b Clinical Trial at 2019 Society for Immunotherapy of Cancer (SITC) Annual MeetingGlobeNewsWire • 11/08/19
Corvus Pharmaceuticals, Inc. (CRVS) CEO Richard Miller on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 10/30/19